General Practice · Kissimmee, FL
NPI
1245216522
Since 2005
Specialty
General Practice
Code 208D00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
719 E Oak St
Kissimmee, FL, 34744
Phone (407) 846-0533
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
11,374 prescriptions
Company payments, 2025
$5,777
From 17 companies
Medicare prescription drug claims, 2024
In 2024, the drug Miguel J Melendez Munoz prescribed most often to Medicare patients was Clonazepam, with 1,084 prescriptions and refills. In total Miguel J Melendez Munoz wrote 11,374 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-28.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clonazepam Generic | 1,084 | 1,091 | 152 | $8,311 |
| Quetiapine Fumarate Generic | 896 | 1,117 | 115 | $11K |
| Alprazolam Generic | 819 | 822 | 97 | $6,475 |
| Trazodone Hcl Generic | 676 | 866 | 102 | $12K |
| Bupropion Xl Bupropion Hcl | 671 | 905 | 89 | $14K |
| Fluoxetine Hcl Generic | 610 | 791 | 65 | $2,831 |
| Buspirone Hcl Generic | 581 | 717 | 93 | $7,997 |
| Temazepam Generic | 476 | 490 | 67 | $3,441 |
| Duloxetine Hcl Generic | 438 | 561 | 57 | $14K |
| Sertraline Hcl Generic | 386 | 497 | 63 | $2,003 |
| Zolpidem Tartrate Generic | 290 | 298 | 48 | $1,439 |
| Lorazepam Generic | 272 | 272 | 40 | $1,349 |
| Aripiprazole Generic | 259 | 324 | 37 | $32K |
| Escitalopram Oxalate Generic | 257 | 366 | 43 | $1,669 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 221 | 302 | 27 | $1,989 |
Brand drugs: 861 claims; generic drugs: 10,513 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Miguel J Melendez Munoz $5,777 ($5,777 in general payments such as food, travel and fees) from 17 companies. The largest payer was Axsome Therapeutics, Inc. with $900.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 25 | $900 |
| Neurocrine BioSciences, Inc. NBIX | 19 | $641 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 28 | $616 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 40 | $594 |
| Teva Pharmaceuticals USA, Inc. TEVA | 29 | $570 |
| Abbvie Inc. ABBV | 31 | $569 |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $417 |
| Alkermes, Inc. ALKS | 24 | $352 |
| Vanda Pharmaceuticals Inc. VNDA | 14 | $304 |
| Lundbeck LLC | 13 | $242 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.